With approximately 3,000 employees and 34 subsidiaries worldwide, Merz has evolved as a leading provider of aesthetics and special neurology. Privately held for more than 100 years, the company is dis...
With approximately 3,000 employees and 34 subsidiaries worldwide, Merz has evolved as a leading provider of aesthetics and special neurology. Privately held for more than 100 years, the company is distinguished by its innovative in-house R&D, solid financial strength and the right strategy for long-term growth. Merz also develops and produces agents and therapies for neurology, OTC medicines, dietary supplements and skincare products. In fiscal year 2015/16 the Merz Pharma Group generated revenue of EUR 1,092.9 million.